NDC 72829-010

Imcivree

Setmelanotide

Imcivree is a Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by Rhythm Pharmaceuticals, Inc. The primary component is Setmelanotide.

Product ID72829-010_2c075332-ae2c-4be0-8ba7-309536362c7e
NDC72829-010
Product TypeHuman Prescription Drug
Proprietary NameImcivree
Generic NameSetmelanotide
Dosage FormSolution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-12-14
Marketing CategoryNDA / NDA
Application NumberNDA213793
Labeler NameRhythm Pharmaceuticals, Inc
Substance NameSETMELANOTIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesMelanocortin 4 Receptor Agonist [EPC], Melanocortin 4 Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 72829-010-01

1 VIAL, MULTI-DOSE in 1 CARTON (72829-010-01) > 1 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date2020-12-14
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Imcivree]

Mark Image

Registration | Serial
Company
Trademark
Application Date
IMCIVREE
IMCIVREE
90178986 not registered Live/Pending
Rhythm Pharmaceuticals, Inc.
2020-09-14
IMCIVREE
IMCIVREE
88226182 not registered Live/Pending
Rhythm Pharmaceuticals, Inc.
2018-12-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.